• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TESTOSTERONE (TSTO); TESTOSTERONE IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TESTOSTERONE (TSTO); TESTOSTERONE IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/05/2014
Event Type  malfunction  
Event Description
Elevated advia centaur xp testosterone results were obtained on samples from two different patients.Redraw samples were tested for both patients two weeks later and the results were in the normal reference range.The discordant results were questioned.No other repeat testing was performed.No testosterone enhancement pharmaceuticals were taken by patients.The patients were tested as part of a routine physical.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the discordant advia centaur xp testosterone result.
 
Manufacturer Narrative
The cause for the discordant advia centaur xp testosterone results is unknown.The cause for the elevated results maybe from pre-analytical factors during sample collection.The samples from the patients are not available for further testing and investigation.The instrument is performing within specification.No further evaluation of the device is required.The ifu states specimen collection and handling section: "before placing samples on the system, ensure that samples have the following characteristics: -samples are free of fibrin or other particulate matter.-samples are free of bubbles.".
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2014-00214 on august 14, 2014.On 10/14/2014 additional information: clarification was received regarding the initial result reported for patient 1.The initial result reported for patient 1 was 13,000 ng/dl.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP TESTOSTERONE (TSTO)
Type of Device
TESTOSTERONE IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
east walpole, MA 02032
5086604603
MDR Report Key4008720
MDR Text Key4693037
Report Number1219913-2014-00214
Device Sequence Number1
Product Code CDZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K934562
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Health Professional
Remedial Action Inspection
Type of Report Initial,Followup
Report Date 07/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/17/2014
Device Model NumberN/A
Device Catalogue Number05476206
Device Lot Number167
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/14/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-